JPWO2016136556A1 - パップ剤 - Google Patents
パップ剤 Download PDFInfo
- Publication number
- JPWO2016136556A1 JPWO2016136556A1 JP2017502295A JP2017502295A JPWO2016136556A1 JP WO2016136556 A1 JPWO2016136556 A1 JP WO2016136556A1 JP 2017502295 A JP2017502295 A JP 2017502295A JP 2017502295 A JP2017502295 A JP 2017502295A JP WO2016136556 A1 JPWO2016136556 A1 JP WO2016136556A1
- Authority
- JP
- Japan
- Prior art keywords
- extract
- base fabric
- water
- plaster
- fabric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Knitting Of Fabric (AREA)
Abstract
Description
損失正接(tanδ)=損失弾性率(G”)/貯蔵弾性率(G’)
基布A〜Cを、編目に対してコース方向又はウェール方向に伸ばしたときの応力を測定した。すなわち、基布をコース方向又はウェール方向に対して、特定のモジュラスとなるまでの距離だけ伸ばした際に、基布にかかる応力を測定した。なお、「伸び」とは、例えば、「測定開始点」と記載された場合には、全く伸ばしていない状態の基布を意味し、「10%モジュラス」と記載された場合には、歪が10%になるように、基布を測定開始点からコース方向又はウェール方向に伸ばした状態を意味する。
基布A、B及びCを、編目に対してコース方向又はウェール方向に伸ばしたときの伸張回復率(%)、剛軟度(mm)、50%モジュラス(N/5cm)を測定した。伸張回復率、剛軟度の測定方法は、JIS L 1096:2010に記載の方法にしたがって、測定した。
試料として実施例1の膏体液を用いて、以下の条件により損失弾性率及び貯蔵弾性率を測定し、損失正接(tanδ値)を算出した。
[測定条件]
装置:回転式レオメータ(レオメトリック・サイエンティフィック・エフ・イー株式会社製)
試料部:直径25mmの平行平板
ギャップ間隔:7mm
試料量:2〜3g
温度:32℃
周波数:1Hz
歪:1%
表5に記載の組成にしたがい、実施例2〜4及び比較例1〜2の膏体液を調製した。なお、表5中の数字は、質量部を意味する。
得られた実施例2〜4及び比較例1〜2の膏体液について、粘度測定及び動的粘弾性測定を行なった。なお、粘度測定は膏体液の調製直後に行い、動的粘弾性測定は膏体液の調製から2.5時間後及び1か月後に行った。
結果を表6に示す。ポリアクリル酸部分中和物の含有量を増加させることにより、膏体液の粘度は高くなり、動的粘弾性測定におけるtanδ値は減少した。
実施例1又は比較例1の膏体液を、基布B又はCにそれぞれ展延し、パップ剤を調製した。
得られたパップ剤の基布について、膏体層と接している面と反対側の面を指で触れた場合に、試験者の指に液体が付着し、べたつきを感じるかどうかで評価した。なお、評価結果については、べたつきを感じたときを「×」として記載し、べたつきを感じなかったときを「○」として記載した。
結果を表7に示す。比較例1の膏体液を用いると、染み出しが観察されたのに対し、実施例1の膏体液を用いると、染み出しは観察されなかった。
実施例1又は比較例2の膏体液を、基布A〜Cにそれぞれ展延し、パップ剤を調製した。得られたパップ剤を、被験者15名の肘部または腰部の左右の皮膚に1枚ずつ貼付し、貼付から8時間後及び24時間後のパップ剤の剥離状態を、目視により評価した。なお、評価は、貼付してから8時間後又は24時間後において、パップ剤の皮膚から剥離している面積の、貼付した時の皮膚に接している面積に対する割合に基づいて、表8に記載の評価基準にしたがって、行った。
Claims (8)
- 基布上に膏体層を備えるパップ剤の製造方法であって、
生理活性物質、水溶性ポリマー、グリセリン及び水を含有する組成物を、前記基布に塗布して膏体層を形成する工程を含み、
前記基布に塗布する時点の、前記組成物の1Hzでの動的粘弾性測定における損失正接が0.75〜1である、方法。 - 前記基布が編布であり、
該編布の伸長回復率は、コース方向で73〜98%であり、ウェール方向で83〜98%である、請求項1に記載の方法。 - 前記基布が編布であり、
該編布の剛軟度は、コース方向で10〜15mmであり、ウェール方向で10〜18mmである、請求項1又は2に記載の方法。 - 前記基布が編布であり、
該編布について、コース方向での50%モジュラスに対する、ウェール方向での50%モジュラスの値が、0.8〜1.2である、請求項1〜3のいずれか一項に記載の方法。 - 前記水溶性ポリマーが、ポリアクリル酸又はポリアクリル酸中和物を含有する、請求項1〜4のいずれか一項に記載の方法。
- 前記組成物が、アクリル酸メチル・アクリル酸2−エチルヘキシル共重合体樹脂を含有する、請求項1〜5のいずれか一項に記載の方法。
- 前記水溶性ポリマーの含有量が、前記膏体層の全質量基準で3〜18質量%である、請求項1〜6のいずれか一項に記載の方法。
- 請求項1〜7のいずれか一項に記載の方法により得られるパップ剤。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015033981 | 2015-02-24 | ||
JP2015033981 | 2015-02-24 | ||
JP2015080888 | 2015-04-10 | ||
JP2015080888 | 2015-04-10 | ||
PCT/JP2016/054570 WO2016136556A1 (ja) | 2015-02-24 | 2016-02-17 | パップ剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2016136556A1 true JPWO2016136556A1 (ja) | 2017-09-28 |
JP6434123B2 JP6434123B2 (ja) | 2018-12-05 |
Family
ID=56789466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017502295A Active JP6434123B2 (ja) | 2015-02-24 | 2016-02-17 | パップ剤 |
Country Status (9)
Country | Link |
---|---|
US (2) | US10940121B2 (ja) |
EP (1) | EP3263097B1 (ja) |
JP (1) | JP6434123B2 (ja) |
KR (1) | KR101913055B1 (ja) |
CN (1) | CN107106513B (ja) |
ES (1) | ES2894742T3 (ja) |
HK (1) | HK1247819A1 (ja) |
TW (1) | TWI702058B (ja) |
WO (1) | WO2016136556A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10940121B2 (en) * | 2015-02-24 | 2021-03-09 | Hisamitsu Pharmaceutical Co., Inc. | Gel patch |
BR112019014346A2 (pt) * | 2017-02-21 | 2020-02-27 | Hisamitsu Pharmaceutical Co., Inc. | Base de emplastro e emplastro usando a mesma |
JP2020066592A (ja) * | 2018-10-24 | 2020-04-30 | 帝國製薬株式会社 | 水性貼付剤 |
BR112021015884A2 (pt) | 2019-02-14 | 2021-10-05 | Hisamitsu Pharmaceutical Co., Inc. | Cataplasma |
AU2020286067A1 (en) * | 2019-05-31 | 2022-01-06 | Sumitomo Chemical Company, Limited | Liquid suspension concentrate formulation comprising mefentrifluconazole |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003155252A (ja) * | 2001-11-19 | 2003-05-27 | Toagosei Co Ltd | パップ剤基剤 |
JP2003531955A (ja) * | 2000-05-04 | 2003-10-28 | キンバリー クラーク ワールドワイド インコーポレイテッド | イオン感応性で水に分散可能なポリマー、その製造方法及びそれを用いた物品 |
WO2004047820A1 (ja) * | 2002-11-27 | 2004-06-10 | Hisamitsu Pharmaceutical Co., Inc. | 温感パップ剤 |
WO2006070672A1 (ja) * | 2004-12-28 | 2006-07-06 | Kowa Co., Ltd. | 含水型貼付剤 |
JP2007039451A (ja) * | 2005-07-07 | 2007-02-15 | Saitama Daiichi Seiyaku Kk | 含水系粘着剤組成物及びそれを用いた貼付剤 |
JP2007320939A (ja) * | 2006-06-05 | 2007-12-13 | Toagosei Co Ltd | パップ剤用基剤および膏体 |
WO2012102242A1 (ja) * | 2011-01-24 | 2012-08-02 | ニプロパッチ株式会社 | 含水系貼付剤 |
JP2013082650A (ja) * | 2011-10-07 | 2013-05-09 | Kao Corp | 貼付剤用ゲル及びそれを有する貼付剤 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS604125A (ja) | 1983-06-22 | 1985-01-10 | Sekisui Chem Co Ltd | 貼着薬 |
US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
JP2837337B2 (ja) | 1993-08-10 | 1998-12-16 | 帝三製薬株式会社 | 貼付剤 |
CN1081030C (zh) | 1996-02-07 | 2002-03-20 | 立德化学株式会社 | 含有曲尼司特的外用制剂及其制备方法 |
JPH1112910A (ja) | 1997-06-12 | 1999-01-19 | Teijin Ltd | 医療用貼付材基布およびその製造方法 |
JPH11188054A (ja) | 1997-12-25 | 1999-07-13 | Lion Corp | 皮膚外用部材 |
JP2000143503A (ja) * | 1998-11-11 | 2000-05-23 | Ooshin Seiyaku Kk | 外用貼付剤 |
WO2001066095A1 (fr) | 2000-03-07 | 2001-09-13 | Teijin Limited | Timbre extensible |
JP2001302503A (ja) | 2000-04-17 | 2001-10-31 | Oishi Koseido:Kk | 貼付剤 |
JP2001328935A (ja) * | 2000-05-19 | 2001-11-27 | Hisamitsu Pharmaceut Co Inc | 貼付剤 |
JP5004789B2 (ja) | 2005-02-23 | 2012-08-22 | ニプロパッチ株式会社 | 含水系外用貼付剤用組成物及びこの組成物を用いた貼付剤 |
JP5243792B2 (ja) | 2005-06-01 | 2013-07-24 | ニプロパッチ株式会社 | 貼付剤 |
JP4982101B2 (ja) | 2006-03-31 | 2012-07-25 | 花王株式会社 | 剥離型パック化粧料 |
JP2008037798A (ja) * | 2006-08-07 | 2008-02-21 | Bando Chem Ind Ltd | 皮膚貼付薬シート |
WO2010073327A1 (ja) | 2008-12-24 | 2010-07-01 | リードケミカル株式会社 | 貼付剤 |
US20120102242A1 (en) * | 2010-10-26 | 2012-04-26 | Kaminario Technologies Ltd. | Controlling data destaging within a multi-tiered storage system |
CN103313710A (zh) | 2010-11-02 | 2013-09-18 | 积水医疗株式会社 | 贴剂 |
EP2749279A4 (en) | 2011-08-25 | 2015-01-21 | Nipro Patch Co Ltd | AQUEOUS SKIN CARBIDE |
CN105473132B (zh) * | 2013-08-23 | 2019-01-29 | 久光制药株式会社 | 泥罨剂及其制造方法 |
BR112017013255B1 (pt) * | 2014-12-22 | 2022-08-09 | Hisamitsu Pharmaceutical Co., Inc | Cataplasma |
US10940121B2 (en) * | 2015-02-24 | 2021-03-09 | Hisamitsu Pharmaceutical Co., Inc. | Gel patch |
-
2016
- 2016-02-17 US US15/551,916 patent/US10940121B2/en active Active
- 2016-02-17 CN CN201680004916.1A patent/CN107106513B/zh active Active
- 2016-02-17 JP JP2017502295A patent/JP6434123B2/ja active Active
- 2016-02-17 ES ES16755303T patent/ES2894742T3/es active Active
- 2016-02-17 EP EP16755303.1A patent/EP3263097B1/en active Active
- 2016-02-17 KR KR1020177022017A patent/KR101913055B1/ko active IP Right Grant
- 2016-02-17 WO PCT/JP2016/054570 patent/WO2016136556A1/ja active Application Filing
- 2016-02-23 TW TW105105313A patent/TWI702058B/zh active
-
2018
- 2018-06-01 HK HK18107226.1A patent/HK1247819A1/zh unknown
-
2021
- 2021-02-04 US US17/167,498 patent/US20210154152A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003531955A (ja) * | 2000-05-04 | 2003-10-28 | キンバリー クラーク ワールドワイド インコーポレイテッド | イオン感応性で水に分散可能なポリマー、その製造方法及びそれを用いた物品 |
JP2003155252A (ja) * | 2001-11-19 | 2003-05-27 | Toagosei Co Ltd | パップ剤基剤 |
WO2004047820A1 (ja) * | 2002-11-27 | 2004-06-10 | Hisamitsu Pharmaceutical Co., Inc. | 温感パップ剤 |
WO2006070672A1 (ja) * | 2004-12-28 | 2006-07-06 | Kowa Co., Ltd. | 含水型貼付剤 |
JP2007039451A (ja) * | 2005-07-07 | 2007-02-15 | Saitama Daiichi Seiyaku Kk | 含水系粘着剤組成物及びそれを用いた貼付剤 |
JP2007320939A (ja) * | 2006-06-05 | 2007-12-13 | Toagosei Co Ltd | パップ剤用基剤および膏体 |
WO2012102242A1 (ja) * | 2011-01-24 | 2012-08-02 | ニプロパッチ株式会社 | 含水系貼付剤 |
JP2013082650A (ja) * | 2011-10-07 | 2013-05-09 | Kao Corp | 貼付剤用ゲル及びそれを有する貼付剤 |
Also Published As
Publication number | Publication date |
---|---|
US20210154152A1 (en) | 2021-05-27 |
JP6434123B2 (ja) | 2018-12-05 |
US10940121B2 (en) | 2021-03-09 |
EP3263097A1 (en) | 2018-01-03 |
CN107106513A (zh) | 2017-08-29 |
KR20170102965A (ko) | 2017-09-12 |
TW201642841A (zh) | 2016-12-16 |
US20180036255A1 (en) | 2018-02-08 |
KR101913055B1 (ko) | 2018-10-29 |
ES2894742T3 (es) | 2022-02-15 |
HK1247819A1 (zh) | 2018-10-05 |
EP3263097A4 (en) | 2018-08-15 |
EP3263097B1 (en) | 2021-08-25 |
CN107106513B (zh) | 2021-03-02 |
WO2016136556A1 (ja) | 2016-09-01 |
BR112017017287A2 (pt) | 2018-04-10 |
TWI702058B (zh) | 2020-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6434123B2 (ja) | パップ剤 | |
KR101800564B1 (ko) | 파프제 및 그 제조 방법 | |
JP7201780B2 (ja) | パップ剤 | |
JP6469136B2 (ja) | パップ剤 | |
KR102664518B1 (ko) | 파프제 | |
WO2020166665A1 (ja) | パップ剤 | |
JP2020132637A (ja) | パップ剤 | |
JP2020066592A (ja) | 水性貼付剤 | |
BR112017017287B1 (pt) | Curativo em gel e método para sua produção |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170613 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180403 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180514 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181030 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181107 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6434123 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |